Kintara Therapeutics Inc (KTRA) Stock Volatility: Beta and Market Fluctuations

In other words, the price has increased by $0.0000 from its previous closing price. On the day, 2977178 shares were traded.

Ratios:

To gain a deeper understanding of KTRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KTRA now has a Market Capitalization of 3.58M and an Enterprise Value of 13.17M.

Stock Price History:

Over the past 52 weeks, KTRA has reached a high of $5.98, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is 0.1117, while the 200-Day Moving Average is calculated to be 2.1191.

Shares Statistics:

It appears that KTRA traded 13.29M shares on average per day over the past three months and 19.43M shares per day over the past ten days. A total of 39.04M shares are outstanding, with a floating share count of 38.96M. Insiders hold about 0.19% of the company’s shares, while institutions hold 0.62% stake in the company. Shares short for KTRA as of Feb 29, 2024 were 2.19M with a Short Ratio of 0.16, compared to 164.04k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.61% and a Short% of Float of 5.62%.

Earnings Estimates

As of right now, 0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$3.5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.46 and -$0.46 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.38, with 1 analysts recommending between -$0.38 and -$0.38.

Most Popular

[the_ad id="945"]